Skip to main content
OpenTrials
Completed

NCT Number: NCT04394741

Effects of Dry Needling on Stiffness in Latent Trigger Points

The purpose of this study is to determine whether application of Dry Needling (DN) is effective for reduced on Stiffness in Latent trigger point (LTrP) of upper trapezius. The secondary purposes are to determine the correlation on two elastography for stiffness measure (Shear-wave elastography and Strain elastography). Randomized controlled trial, in parallel with cross-control design. Two groups with LTrP in upper trapezius, and will be randomly selected to DN group or Sham-Dn group.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Performance and Sport Rehabilitation Laboratory

Toledo, 45071, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 30 years
  • The presence of LTrP in the middle third of the upper trapezius muscle on the dominant side
  • Being able to provide written informed consent
  • Being able to follow instructions and realize clinical tests

Exclusion criteria

  • Any pharmacological therapeutic
  • Any medical treatment or physical therapies at cervical region during the 6-month before this study - Any diagnosed health problem
  • Any history of head and upper extremity surgery or trauma
  • Any red flags to DN, (ie: metabolic diseases, pregnancy, kinesiophobia, Infection, cancer)
  • Absence of recurrent history of neck pain
  • No neck pain symptomatology the previous 6 months
  • Cervical disk herniation

Treatment and study plan

Intervention-Dry Needling

Device

Deep Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle.

1 session in upper trapezius muscle moving the needle up and down ten times.

Control-Dry Needling

Device

Sham Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle with non-penetrating needles

1 session in upper trapezius muscle moving the needle up and down ten times.

Primary outcomes

  1. Change on Stiffness (Shear wave elastography and Strain Elastography)

    Time frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

    Shear-wave Elastography (SWE) as assessed using an Logiq S8 US system (GE Healthcare).

    The stiffness was determined with measuring velocity of shear waves in trapezius muscle on SWE exam.

    Strain elastography (SEL) as assessed using an Logiq S8 US system (GE Healthcare).

    The stiffness was determined by applying light repetitive compression with the hand-held transducer

Secondary outcomes

  1. Change in Pain Pressure Threshold (PPT)

    Time frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

    Pressure-Pain Threshold as assessed by an manual mechanical algometer. PPT is the minimal amount of pressure that produces pain and is used to assess abnormalities in nociceptive processing or hyperalgesia.

  2. Change in Thickness of muscle

    Time frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

    The muscle was scanned in the longitudinal and axial planes, taking care to avoid anisotropy. B-Mode gray scale was employed to measure muscle thickness

  3. Change in Post-needling soreness

    Time frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

    The procedure performed was the subject had to characterize the level of pain using a visual analog scale (VAS), ranging from 0mm (no pain) to 10mm (worst imaginable pain)

Sponsors and collaborators

Lead sponsor

University of Castilla-La Mancha

Other

Registry information

Official study title

Effects of Dry Needling on Stiffness in Latent Myofascial Trigger Points: a Randomized Controlled Trial

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
May 19, 2020
Registry last updated
Oct 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.